Follow the Science: How Big Pharma Misleads, Obscures, and Prevails

by Sharyl Attkisson

When split into these smaller classifications, no single category rose to the level of a worrisome liver signal. Had they been properly clustered together, it would have amounted to a five-alarm fire, according to the FDA official.